首页> 外国专利> TECHNIQUES FOR IMPROVED AUTOMATIC DRUG DELIVERY PERFORMANCE USING DELIVERY TENDENCIES FROM PAST DELIVERY HISTORY AND USE PATTERNS

TECHNIQUES FOR IMPROVED AUTOMATIC DRUG DELIVERY PERFORMANCE USING DELIVERY TENDENCIES FROM PAST DELIVERY HISTORY AND USE PATTERNS

机译:利用过去送货历史的交付趋势改善自动药物交付性能的技术,并使用模式

摘要

Disclosed are devices, a system, methods and computer-readable medium products that provide techniques to implement functionality to determine when to softened upper bounds of drug delivery and how much to soften the upper bound. Future blood glucose measurement values may be predicted by calculating deviations between predicted blood glucose measurement values and additional blood glucose measurement values. A gain parameter may be determined for use with a model of predicting a users blood glucose measurement values and determining future drug dosages. Safety constraints may be determined based on an evaluation of missing blood glucose measurement values. In addition, safety constraints may be determined based on an evaluation of a user's increased interaction with an automatic drug delivery device. A bolus uncertainty metric to determine an amount of insulin to be provided in a bolus dosage in response to a bolus request may be calculated.
机译:公开了提供了提供技术以实现功能以确定何时软化药物递送的何时软化的技术的装置,系统,方法和计算机可读介质产品以及软化上限的何时软化。可以通过计算预测血糖测量值和附加血糖测量值之间的偏差来预测未来的血糖测量值。可以确定增益参数,以便与预测用户血糖测量值的模型一起使用,并确定未来的药物剂量。可以基于对缺失血糖测量值的评估来确定安全约束。另外,可以基于用户与自动药物输送装置的增加的交互的评估来确定安全约束。可以计算用于确定响应于推注请求的推注剂量中提供胰岛素的胰岛素的推注的不确定性度量。

著录项

  • 公开/公告号WO2021126915A1

    专利类型

  • 公开/公告日2021-06-24

    原文格式PDF

  • 申请/专利权人 INSULET CORPORATION;

    申请/专利号WO2020US65226

  • 申请日2020-12-16

  • 分类号A61B5;A61B5/145;A61M5/142;G16H20/17;G16H50;

  • 国家 US

  • 入库时间 2022-08-24 19:36:11

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号